Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/GENENTA-SCIENCE-S-P-A-130728144/nieuws/FDA-kent-weesgeneesmiddel-toe-aan-Temferon-voor-de-behandeling-van-Glioblastoma-Multiforme-43147540/?utm_source=whatsapp&utm_medium=social&utm_campaign=share